Search Within

Raajit Kumar Rampal

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (17)
  3. Research Letter (2)
Groups
  1. Adult Leukemia (39)
  2. Biostatistics Service (39)
  3. Center for Hematologic Malignancies (39)
  4. Department of Medicine (39)
  5. Epidemiology and Biostatistics (39)
  6. Hematologic Malignancies, Division of (39)

More Groups

People
  1. Sean Devlin (17)
  2. Ross Levine (16)
  3. Andriy Derkach (15)
  4. Eytan Stein (13)
  5. Martin Tallman (13)
  6. Omar Abdel-Wahab (9)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (11)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (2)

More Years

Publications
  1. Blood (19)
  2. Blood Advances (3)
  3. American Journal of Hematology (2)
  4. British Journal of Haematology (2)
  5. Haematologica (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (22)
  2. John Wiley & Sons (3)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (2)
  5. Ferrata Storti Foundation (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (39)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • A phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Verstovsek, S.; Derkach, A.; Masarova, L.; Pemmaraju, N.; Stein, E. M.; Mauro, M. J.; Rampal, R.; Bose, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Spleen volume reduction (SVR) predicts overall survival (OS) in myelofibrosis (MF) patients on pacritinib (PAC) but not best available therapy (BAT): PERSIST-2 landmark OS analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J. M.; Gerds, A. T.; Kiladjian, J. J.; Derkach, A.; Rampal, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/ essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Verstovsek, S.; Derkach, A.; Masarova, L.; Pemmaraju, N.; Stein, E.; Mauro, M.; Rampal, R. K.; Bose, P.
    Blood (2022)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation
    Journal Article

    Li, B.; An, W.; Wang, H.; Baslan, T.; Mowla, S.; Krishnan, A.; Xiao, W.; Koche, R. P.; Liu, Y.; Cai, S. F.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms
    Research Letter

    King, A. C.; Weis, T. M.; Derkach, A.; Ball, S.; Pandey, M.; Mauro, M. J.; Goldberg, A. D.; Stahl, M.; Famulare, C.; Tallman, M. S.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
    Research Letter

    Kozak, K. E.; Ouyang, L.; Derkach, A.; Sherman, A.; McCall, S. J.; Famulare, C.; Chervin, J.; Daley, R. J.; Morjaria, S.; Mauro, M. J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Therapeutic efficacy of combined JAK1/2, pan-PIM, and CDK4/6 inhibition in myeloproliferative neoplasms
    Journal Article

    Rampal, R. K.; Pinzon-Ortiz, M.; Hanasoge Somasundara, A. V.; Durham, B.; Koche, R.; Spitzer, B.; Mowla, S.; Krishnan, A.; Li, B.; An, W.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia
    Journal Article

    Xiao, W.; Chan, A.; Waarts, M. R.; Mishra, T.; Liu, Y.; Cai, S. F.; Yao, J.; Gao, Q.; Bowman, R. L.; Koche, R. P.; more...
    Blood (2021)

    Fulltext@MSK | Save